LoginRegister
    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive servicesParas Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services
    Shilpa Medicare gets final USFDA approval for Gemcitabine InjectionShilpa Medicare gets final USFDA approval for Gemcitabine Injection
    Takeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBDTakeda Pharma, Prometheus Biosciences collaborate to develop therapies for IBD
    CDSCO Committee to draft new guidelines for effective recall of substandard drugsCDSCO Committee to draft new guidelines for effective recall of substandard drugs
    Dr Reddys gets Establishment Inspection Report from USFDA for Bollaram facilityDr Reddys gets Establishment Inspection Report from USFDA for Bollaram facility
    Indoco Remedies Parkinsons drug Rasagiline gets USFDA okayIndoco Remedies Parkinsons drug Rasagiline gets USFDA okay
    Glenmark API facility in Baddi gets USFDA warning letterGlenmark API facility in Baddi gets USFDA warning letter
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030
    Bayer another US glyphosate trial delayed until further noticeBayer another US glyphosate trial delayed until further notice
    ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademarkZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark
    Lupin gets USFDA nod for generic equivalet of DilantinLupin gets USFDA nod for generic equivalet of Dilantin
    Novartis, Microsoft collaborate to transform medicine with AINovartis, Microsoft collaborate to transform medicine with AI
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X